Sahibzada Ajit Singh Nagar
08048047521
What to Do When Allergy Demand Needs a Tablets Range

A distributor facing allergy demand must first separate symptom-led demand from requests for a familiar brand name. By the end, you will be able to decide when one SKU is enough, when a molecule-and-strength range is justified, and how to verify, forecast and promote each pack safely.

Key takeaways

  • Start with sneezing, itching and rhinorrhoea before requesting a brand.
  • Match each molecule and strength to a documented prescribing role.
  • Track demand, expiry risk and reorder levels at SKU level.
  • Verify licence, batch, expiry and pack details before Arizine 180 tab procurement.

Start with the symptom pattern, not the brand request

Sneezing, nasal itching and clear rhinorrhoea point toward demand for an oral antihistamine. Persistent nasal blockage points elsewhere: intranasal corticosteroids generally control congestion better, so a tablet-only range will leave part of the allergic-rhinitis demand unmet. An Arizine tablets range for allergy demand problems should begin with symptoms, not with the brand name.

  • Stock one tablet SKU when local prescriptions and pharmacy requests concentrate on one active ingredient, one adult strength and one recurring symptom pattern. Confirm this with sales records rather than assuming that pack movement equals patient demand.
  • Add a wider range when the territory separates into distinct prescribing roles: bilastine 20 mg, fexofenadine 120 mg, fexofenadine 180 mg, cetirizine or levocetirizine strengths, paediatric liquids or tablets, and combination products. These are not interchangeable by milligram or by patient group.
  • Keep combination products separate from single-ingredient tablets. A montelukast combination needs a defined prescribing rationale; it is not an automatic choice for every allergy complaint.
  • Increase seasonal cover when pollen or environmental-trigger periods drive sales, but retain a baseline for perennial symptoms. Do not apply one monthly run rate to every SKU.

Before expanding an allergy product range for distributors, ask whether the request reflects allergic rhinitis, urticaria, a viral cold, bacterial infection or an asthma-related complaint. Fever, wheeze, breathing difficulty, facial pain or thick persistent discharge requires clinical assessment, not wider tablet promotion. Verify Arizine’s active ingredient and strength before treating it as a stocking category.

Match each molecule and strength to its prescribing role

Do not treat 20 mg, 120 mg and 180 mg as interchangeable inventory. Match the active ingredient and strength to the prescribing role, then check whether the complaint is allergic rhinitis, urticaria, a viral cold, bacterial infection or an asthma-related symptom before recommending any tablet.

OptionWhat it meansWhen it applies
Bilastine 20 mgSingle-ingredient, once-daily antihistamine strengthA non-sedating antihistamine option for allergic rhinitis or urticaria in the labelled age group; keep it separate from fexofenadine stock
Fexofenadine 120 mgSingle-ingredient lower adult strengthCommonly associated with seasonal allergic rhinitis; it is not a milligram-for-milligram substitute for bilastine 20 mg
Fexofenadine 180 mgHigher adult strengthUsed for labelled adult or adolescent indications such as seasonal allergic rhinitis; do not use it automatically for children, renal impairment or another indication
Arizine-BL or Arizine-MCombination product, not a plain antihistamine tabletVerify the current pack’s ingredients and indication; montelukast needs a defined prescribing rationale, not routine use for every allergy complaint

For an Arizine tablet range, record the active ingredient, strength, dosage form, approved indication and patient segment for every SKU. Confirm the label before substitution because a brand name alone does not establish pharmacological identity.

Fexofenadine counselling also belongs in the range plan: take it with water, since apple, orange and grapefruit juice can reduce exposure.

Build the stock file around SKU-level demand and risk

A SKU is a distinct purchasing unit, not a colour or brand family. Record active ingredient, strength, release type, pack size, storage requirement, statutory label status and supplier continuity for every line.

ProductPrescribing roleStocking implication
Bilastine 20 mgSingle-ingredient antihistamine for allergic-rhinitis or urticaria demandTrack separately; do not substitute by milligram
Fexofenadine 120 mgLower-strength adult SKU for territory-specific prescribingForecast independently from 180 mg
Fexofenadine 180 mgHigher-strength adult SKU for selected prescribing needsKeep separate from paediatric and renal-caution demand
Cetirizine or levocetirizineAlternative antihistamine strengths with their own prescribing patternsAdd only when local prescriptions justify them
Combination productAntihistamine plus another active ingredient, such as Arizine-BL or Arizine-MRequire a defined indication; never treat as a single-agent substitute

Build demand fields around monthly units, prescription or invoice count, active prescriber count, average units per order, lost orders and days of stockout. Add territory, customer type and month so pollen-related peaks do not get confused with the steadier baseline from perennial symptoms.

Use these inventory fields:

  • Batch number, manufacture date, expiry date and quantity
  • FEFO pick date and months remaining at dispatch
  • Minimum stock, reorder point, target stock and supplier lead time
  • Damaged, quarantined, returned and near-expiry quantities
  • Paediatric-formulation and renal-caution flags

For an anti allergy tablets franchise, flag beverage-counselling requirements such as avoiding apple, orange or grapefruit juice with fexofenadine. A high reorder point for Arizine 180 tab can create expiry risk if demand is seasonal, so set it from SKU-level movement rather than total allergy sales.

Turn an Arizine 180 tab supply request into a procurement check

Do not accept an arizine 180 tab supply—or promise repeat orders—until you verify the product, batch and commercial terms. A brand name alone cannot establish what pharmacies may substitute.

1. Confirm the current pack: active ingredient, exact 180 mg strength, tablet or modified-release form, manufacturer, approved indications, prescription category and statutory label status.

2. Record the batch number, expiry date, available shelf life, storage requirement, pack size, minimum order quantity and lead time. Ask how the supplier will handle a delayed or short-dated batch.

3. Set the substitution rule in writing. Do not exchange 180 mg for fexofenadine 120 mg, bilastine 20 mg, or a montelukast combination without an authorised clinical and commercial decision.

4. If the pack contains fexofenadine hydrochloride 180 mg, check that its approved adult or adolescent seasonal-allergic-rhinitis regimen matches your market’s label. Do not treat it as a universal dose for children, every allergy indication or patients needing renal-dose caution.

5. Request the current product literature and quality documents used in your purchasing process, then brief the pharmacy team on aluminium- or magnesium-containing antacids: separate them from fexofenadine by about two hours.

Focus Healthcare Pvt Ltd can strengthen its distributor checks by logging every batch separately and applying FEFO, or first-expiry, first-out. Set a reorder point for fast-moving 180 mg stock, but cap purchases when demand spikes could leave an adult-strength SKU unsuitable for the next customer.

Related products

Bilastine 20mg

Anti Allergy Tablets

Bilastine 20mg

Arizine 20 Tablet is used to relieve the symptoms of hayfever (sneezing, itchy, runny, blocked-up nose and red and watery eyes) and other forms of...

View product →
ARIZINE - 180 TAB

Anti Allergic

ARIZINE - 180 TAB

₹1700

Composition : Fexofinadine 180mg

View product →

Give medical representatives a claim-and-counselling checklist

Promote an allergy range by tying every claim to its active ingredient, strength, approved indication and label directions. An allergy product range for distributors is safer when pharmacists can see exactly what each SKU contains, rather than relying on pack colour or a brand name.

1. State the molecule and strength: bilastine 20 mg, fexofenadine 120 mg or 180 mg, cetirizine or levocetirizine, paediatric formulations, and any added ingredient. Do not present these as milligram-for-milligram substitutes.

2. Describe fexofenadine as generally less sedating than first-generation antihistamines at recommended doses, not as “non-sedating.” Tell patients to stop and seek advice about driving or hazardous work if drowsiness occurs.

3. Counsel fexofenadine users to take the tablet with water. Apple, orange and grapefruit juice can reduce exposure, so do not claim that every beverage is equivalent.

4. Separate allergic-rhinitis or urticaria claims from viral cold, bacterial infection and asthma-related complaints. Refer patients with breathing difficulty, wheezing, facial swelling or rapidly worsening symptoms for medical care.

5. Identify Arizine by active ingredient, strength, dosage form, manufacturer, prescription category and approved indications before accepting substitution. Arizine-BL and Arizine-M are combination products; montelukast needs a defined prescribing rationale, not an automatic allergy claim.

6. Keep anti allergy tablets franchise materials aligned with the current statutory label, and direct dosing, pregnancy, child-use and interaction questions to a pharmacist or prescriber.

Frequently asked questions

  • Why should allergy demand start with symptoms instead of an Arizine tablet request?

    Sneezing, nasal itching and clear rhinorrhoea suggest oral antihistamine demand, while persistent nasal blockage points toward intranasal corticosteroid demand. A tablet-only range can miss congestion-focused treatment needs.

  • How do you match molecules and strengths to prescribing roles?

    Record the active molecule, strength, dosage form and pack size, then link each SKU to the symptoms and prescriber use it is intended to serve. Do not treat two strengths as interchangeable without checking the approved product information.

  • What belongs in an allergy product range for distributors stock file?

    Track each SKU's molecule, strength, pack size, monthly movement, batch expiry, purchase quantity, reorder point, supplier documents and return or expiry risk.

  • What should you check before accepting an Arizine 180 tab supply request?

    Confirm the requested molecule and strength, pack configuration, licence and supplier documents, batch number, manufacturing date, expiry date, seal condition, quantity and delivery requirements before placing the order.

  • What should medical representatives say when presenting anti allergy tablets?

    Use approved product claims, state the active ingredient and strength accurately, avoid promising treatment for every allergy symptom, and explain label-based directions, precautions and when a patient needs medical advice.

Related products

Arizine-BL

Anti Allergic

Arizine-BL

₹1800

Bilastine 20 mg + Montelukast 10 mg

View product →
Arizine-M

Anti Allergic

Arizine-M

₹1600

Comosition : Fexofenadine 120 mg + Montelukast 10 mg

View product →
Arizine - 20

Anti Allergic

Arizine - 20

₹1500

Composition : Bilastine 20mg

View product →
Nov 19th, 2026 3:00 PM

Keywords